Short-Term Intravenous Fish Oil and Pediatric Intestinal Failure Associated Liver Disease: 3-year Follow-up on Liver Function and Nutrition

Intravenous fish oil (FO) has changed the management of intestinal failure associated liver disease (IFALD). This report describes two IFALD patients who received FO for 5 and 10 months, respectively and reports on their 3-year follow-up.

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Calkins, Kara, Lowe, Allison, Shew, Stephen B., Dunn, James C.Y., Reyen, Laurie, Farmer, Douglas G., Devaskar, Sherin U., Venick, Robert
Format: Artigo
Langue:Inglês
Publié: 2013
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3553503/
https://ncbi.nlm.nih.gov/pubmed/23331820
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpedsurg.2012.10.044
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires